Gwangju Center , Korea Basic Science Institute (KBSI) , Gwangju , 61186 , Korea.
Department of Systems Biotechnology , Chung-Ang University , Anseong , Gyeonggi 17546 , Korea.
ACS Nano. 2020 Feb 25;14(2):1856-1865. doi: 10.1021/acsnano.9b07993. Epub 2020 Jan 10.
Lipid droplet (LD) accumulation, a key feature of foam cells, constitutes an attractive target for therapeutic intervention in atherosclerosis. However, despite advances in cellular imaging techniques, current noninvasive and quantitative methods have limited application in living foam cells. Here, using optical diffraction tomography (ODT), we performed quantitative morphological and biophysical analysis of living foam cells in a label-free manner. We identified LDs in foam cells by verifying the specific refractive index using correlative imaging comprising ODT integrated with three-dimensional fluorescence imaging. Through time-lapse monitoring of three-dimensional dynamics of label-free living foam cells, we precisely and quantitatively evaluated the therapeutic effects of a nanodrug (mannose-polyethylene glycol-glycol chitosan-fluorescein isothiocyanate-lobeglitazone; MMR-Lobe) designed to affect the targeted delivery of lobeglitazone to foam cells based on high mannose receptor specificity. Furthermore, by exploiting machine-learning-based image analysis, we further demonstrated therapeutic evaluation at the single-cell level. These findings suggest that refractive index measurement is a promising tool to explore new drugs against LD-related metabolic diseases.
脂滴(LD)积累是泡沫细胞的一个关键特征,是动脉粥样硬化治疗干预的一个有吸引力的靶点。然而,尽管细胞成像技术取得了进展,但目前的非侵入性和定量方法在活体泡沫细胞中的应用有限。在这里,我们使用光学衍射层析成像(ODT)以无标记的方式对活体泡沫细胞进行定量形态和生物物理分析。我们通过验证相关成像中 ODT 与三维荧光成像的特定折射率来识别泡沫细胞中的 LD。通过对无标记的活体泡沫细胞的三维动力学进行时程监测,我们精确且定量地评估了一种纳米药物(甘露糖-聚乙二醇-乙二醇壳聚糖-异硫氰酸荧光素-洛贝他唑;MMR-Lobe)的治疗效果,该纳米药物旨在根据高甘露糖受体特异性靶向递送至泡沫细胞。此外,通过利用基于机器学习的图像分析,我们进一步在单细胞水平上进行了治疗评估。这些发现表明折射率测量是探索针对 LD 相关代谢疾病的新药的有前途的工具。